X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10) 10
female (9) 9
male (9) 9
middle aged (8) 8
aged (7) 7
risk factors (7) 7
coronary disease (5) 5
coronary disease - mortality (5) 5
myocardial infarction - mortality (5) 5
acute myocardial infarction (4) 4
clinical medicine (4) 4
coronary artery disease (4) 4
coronary disease - drug therapy (4) 4
double-blind method (4) 4
klinisk medicin (4) 4
medical and health sciences (4) 4
medicin och hälsovetenskap (4) 4
mexico (4) 4
benzaldehydes - administration & dosage (3) 3
benzaldehydes - adverse effects (3) 3
cardiac and cardiovascular systems (3) 3
coronary heart disease (3) 3
follow-up studies (3) 3
index medicus (3) 3
kardiologi (3) 3
lipoprotein (3) 3
mortality (3) 3
myocardial infarction (3) 3
myocardial infarction - epidemiology (3) 3
original research (3) 3
oximes - administration & dosage (3) 3
oximes - adverse effects (3) 3
phospholipase a2 inhibitors - administration & dosage (3) 3
phospholipase a2 inhibitors - adverse effects (3) 3
prospective studies (3) 3
stroke - mortality (3) 3
treatment (3) 3
1-alkyl-2-acetylglycerophosphocholine esterase - metabolism (2) 2
acute disease (2) 2
adult (2) 2
atherosclerosis (2) 2
biomarkers (2) 2
biomarkers - metabolism (2) 2
cardiac & cardiovascular systems (2) 2
chlamydia trachomatis (2) 2
chlamydophila pneumoniae (2) 2
chlamydophila psitacii (2) 2
coronariopatía (2) 2
coronary disease - enzymology (2) 2
coronary disease - physiopathology (2) 2
death (2) 2
factores de riesgo (2) 2
infarto agudo del miocardio (2) 2
inflammation (2) 2
kaplan-meier estimate (2) 2
lipids (2) 2
mexico - epidemiology (2) 2
myocardial infarction - etiology (2) 2
myocardial infarction - immunology (2) 2
méxico (2) 2
pharmacology (2) 2
registries (2) 2
risk (2) 2
risk assessment (2) 2
stability investigators (2) 2
stroke (2) 2
stroke - etiology (2) 2
11 medical and health sciences (1) 1
abridged index medicus (1) 1
activating-factor acetylhydrolase (1) 1
acute coronary syndrome - epidemiology (1) 1
acute coronary syndromes (1) 1
acute ischemic heart disease (1) 1
affect (1) 1
aged, 80 and over (1) 1
aging (1) 1
algorithms (1) 1
angina (1) 1
angina, unstable - diagnosis (1) 1
angina, unstable - therapy (1) 1
antibodies (1) 1
antibodies - blood (1) 1
antibodies - immunology (1) 1
antibodies, bacterial - blood (1) 1
anticoagulants - administration & dosage (1) 1
anticoagulants - classification (1) 1
anticoagulants - therapeutic use (1) 1
antimyocardium antibodies (1) 1
arteriosclerosis (1) 1
assaigs clínics de medicaments (1) 1
associations (1) 1
atherogenesis in animals (1) 1
atherosclerotic plaque (1) 1
benzaldehydes (1) 1
benzaldehydes - therapeutic use (1) 1
blood pressure - physiology (1) 1
cardiac patients (1) 1
cardiovascular agents (1) 1
cardiovascular disease (1) 1
cardiovascular diseases (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 18, pp. 1702 - 1711
Darapladib, an oral inhibitor of lipoprotein-associated phospholipase A2, was compared with placebo in 15,828 patients with stable coronary heart disease.... 
TRIAL | LIPOPROTEIN | MEDICINE, GENERAL & INTERNAL | THERAPY | ACTIVATING-FACTOR ACETYLHYDROLASE | OXIDIZED LDL | RISK | PHOSPHOLIPASE A | ATHEROSCLEROTIC PLAQUE | INHIBITOR | CLINICAL-OUTCOMES | Stroke - prevention & control | Double-Blind Method | Follow-Up Studies | Oximes - adverse effects | Phospholipase A2 Inhibitors - administration & dosage | Humans | Middle Aged | Kaplan-Meier Estimate | Oximes - administration & dosage | Male | Coronary Artery Disease - drug therapy | Coronary Disease - mortality | Phospholipase A2 Inhibitors - adverse effects | Benzaldehydes - adverse effects | Benzaldehydes - administration & dosage | Coronary Artery Disease - complications | Treatment Failure | Coronary Disease - drug therapy | Female | Aged | Myocardial Infarction - prevention & control | Prevention | Care and treatment | Ischemia | Dosage and administration | Research | Coronary heart disease | Cardiovascular agents | Myocardial infarction | Cerebral infarction | Phospholipase A2 | Clinical trials | Myocardial ischemia | Cardiovascular disease | Angina | Preventive medicine | Coronary artery disease | Phospholipase | Arteriosclerosis | Death | Plasma levels | Drug therapy | Heart diseases | Plaques | Malalties cardiovasculars | Infart de miocardi | Malalties coronàries | Assaigs clínics de medicaments | Cardiovascular diseases | Drug testing | Coronary diseases | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
European Heart Journal, ISSN 0195-668X, 10/2017, Volume 38, Issue 37, pp. 2813 - 2822
Journal Article
Journal of the American Heart Association, ISSN 2047-9980, 06/2016, Volume 5, Issue 6, p. n/a
Background We evaluated lipoprotein‐associated phospholipase A2 (Lp‐PLA2) activity in patients with stable coronary heart disease before and during treatment... 
atherosclerosis | coronary disease | inflammation | lipoprotein | myocardial infarction | Myocardial infarction | Inflammation | Lipoprotein | Coronary disease | Atherosclerosis
Journal Article
New England Journal of Medicine, ISSN 1533-4406, 2014, Volume 370, Issue 18, p. 1702
Background: Elevated lipoprotein-associated phospholipase A(2) activity promotes the development of vulnerable atherosclerotic plaques, and elevated plasma... 
Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin
Journal Article
Journal Article
Journal Article
Salud Publica de Mexico, ISSN 0036-3634, 05/2005, Volume 47, Issue 3, pp. 227 - 233
Determinar si los anticuerpos contra Chlamydophila pneumoniae en pacientes con infarto agudo del miocardio y factores de riesgo coronario se asocian con la... 
Chlamydophila psitacii | Mexico | Chlamydia trachomatis | Acute myocardial infarction | Coronary disease | Chlamydophila pneumoniae | Risk factors | infarto agudo del miocardio | coronariopatía | factores de riesgo | México | Salud
Journal Article
Salud Pública de México, ISSN 0036-3634, 06/2005, Volume 47, Issue 3, pp. 227 - 233
Journal Article
Salud Pública de México, ISSN 0036-3634, 06/2005, Volume 47, Issue 3, pp. 227 - 233
OBJETIVO: Determinar si los anticuerpos contra Chlamydophila pneumoniae en pacientes con infarto agudo del miocardio y factores de riesgo coronario se asocian... 
Health Policy & Services
Journal Article
Salud Pública de México, ISSN 0036-3634, 06/2005, Volume 47, Issue 3, pp. 227 - 233
OBJETIVO: Determinar si los anticuerpos contra Chlamydophila pneumoniae en pacientes con infarto agudo del miocardio y factores de riesgo coronario se asocian... 
infarto agudo del miocardio | coronary disease | risk factors | Chlamydophila psitacii | coronariopatía | factores de riesgo | México | Mexico | Chlamydia trachomatis | Chlamydophila pneumoniae | acute myocardial infarction
Journal Article
Revista médica del Instituto Mexicano del Seguro Social, ISSN 0443-5117, 05/2010, Volume 48, Issue 3, pp. 259 - 264
Journal Article
Cirugia y cirujanos, 01/2012, Volume 80, Issue 1, p. 92
Journal Article
Revista medica del Instituto Mexicano del Seguro Social, ISSN 0443-5117, 05/2010, Volume 48, Issue 3, p. 259
to identify prognostic factors in the National Registry of Acute Coronary Syndromes. patients in medical care units with acute ischemic coronary syndrome... 
Acute Coronary Syndrome - epidemiology | Risk Assessment | Humans | Middle Aged | Female | Male | Mexico | Registries
Journal Article
Journal of the American Heart Association, ISSN 2047-9980, 08/2017, Volume 6, Issue 8, p. n/a
Journal Article